Synthesis and Antitumor Activity of Pyrido-Amsacrine Analogues and Related Compounds
作者:Emilio Llama、Carmen Del Campo、Miguel Capo、Maria Anadón®
DOI:10.1002/jps.2600820309
日期:1993.3
evaluated in the L1210 leukemia system. Almost all the pyrido analogues were tighter DNA-binding ligands than the corresponding amsacrine compounds. The significant inhibition of L1210 produced by pyrido-acridan-7-ones demonstrates that the anilino side chain is not essential for activity, although most of the compounds did not have improved activity compared with amsacrine.
制备了氨ac碱的吡啶基衍生物[4'-(9-ac啶基氨基)甲磺基-间-茴香胺],并在L1210白血病系统中进行了评估。几乎所有的吡啶基类似物都比相应的氨ac碱化合物具有更紧密的DNA结合配体。由吡啶基-ac啶酮-7-酮产生的L1210的显着抑制作用表明苯胺基侧链对于活性不是必需的,尽管与氨苄青霉素相比,大多数化合物的活性都没有提高。